Iontophoresis-Assisted Corneal Collagen Cross-Linking with Epithelial Debridement: Preliminary Results

• Published in: BioMed research international 2016-01, Vol.2016 (2016), p.1-5
• Main Authors: Vinciguerra, Riccardo, Kubrak-Kisza, Magdalena, Legrottaglie, Emanuela F., Rosetta, Pietro, Romano, Vito, Vinciguerra, Paolo, Azzolini, Claudio
• Format: Article
• Language: English
• Subjects: Adult; Biomedical research; Clinical Study; Collagen; Contact lenses; Cornea - diagnostic imaging; Endothelial Cells - cytology; Female; Humans; Iontophoresis - methods; Keratoconus - diagnostic imaging; Keratoconus - therapy; Male; Middle Aged; Prospective Studies; Surgery; Tomography; Vision Tests; Vitamin B; Young Adult
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2016/3720517

Purpose. To report the early outcomes of iontophoresis-assisted corneal collagen cross-linking procedure with epithelial debridement (I-SCXL). Methods. Twenty eyes of twenty patients with progressive keratoconus were included in this prospective clinical study. Best spectacle corrected visual acuity (BSCVA), sphere and cylinder refraction, corneal topography, Scheimpflug tomography, aberrometry, anterior segment optical coherence tomography (AS-OCT), and endothelial cell count were assessed at baseline and at 1, 3, and 6 months of follow-up. The parameters considered to establish keratoconus progression were always proven with differential maps as change in curvature in the cone area of at least 1 diopter obtained with an instantaneous map. Results. Functional parameters showed a significant improvement ( p < 0.05 ) of BSCVA after 3 and 6 months of follow-up. Morphological parameters indicated stabilization of the corneal ectasia during the follow-up; however, a positive trend was noted with a mean flattening of 1.73 D. Minimum pachymetry values showed thinning that remained constant after the treatment. The demarcation line was clearly visible in all patients, reaching a depth of 308.2 ± 37.74 μm. None of the patients had continuous progression of keratoconus or had to repeat cross-linking procedures. Endothelial cell counts did not change significantly ( p > 0.05 ). Conclusion. The early results indicate that the I-SCXL may be able to reduce the treatment time and improve the riboflavin diffusion.